Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies

Clinical trial NCT07644039 · RECRUITING

Trial details

NCT number: NCT07644039
Sponsor: PharmaMar
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignancies

Start date: 2026-05-21
Primary completion: 2029-04-02
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.